| Product Code: ETC7650261 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Duloxetine Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Duloxetine Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Duloxetine Market - Industry Life Cycle |
3.4 Israel Duloxetine Market - Porter's Five Forces |
3.5 Israel Duloxetine Market Revenues & Volume Share, By Strength, 2021 & 2031F |
3.6 Israel Duloxetine Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.7 Israel Duloxetine Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Israel Duloxetine Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.9 Israel Duloxetine Market Revenues & Volume Share, By Dosage Form, 2021 & 2031F |
3.10 Israel Duloxetine Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.11 Israel Duloxetine Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
4 Israel Duloxetine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and acceptance of mental health disorders in Israel |
4.2.2 Growing demand for effective treatment options for depression and anxiety |
4.2.3 Favorable government policies and initiatives promoting mental health awareness and treatment |
4.3 Market Restraints |
4.3.1 High cost of duloxetine compared to other antidepressants |
4.3.2 Side effects associated with duloxetine leading to patient non-compliance |
4.3.3 Stiff competition from alternative treatments and therapies for mental health disorders |
5 Israel Duloxetine Market Trends |
6 Israel Duloxetine Market, By Types |
6.1 Israel Duloxetine Market, By Strength |
6.1.1 Overview and Analysis |
6.1.2 Israel Duloxetine Market Revenues & Volume, By Strength, 2021- 2031F |
6.1.3 Israel Duloxetine Market Revenues & Volume, By 20mg, 2021- 2031F |
6.1.4 Israel Duloxetine Market Revenues & Volume, By 30mg, 2021- 2031F |
6.1.5 Israel Duloxetine Market Revenues & Volume, By 40mg, 2021- 2031F |
6.1.6 Israel Duloxetine Market Revenues & Volume, By 60mg, 2021- 2031F |
6.2 Israel Duloxetine Market, By Drug Class |
6.2.1 Overview and Analysis |
6.2.2 Israel Duloxetine Market Revenues & Volume, By Antidepressants, 2021- 2031F |
6.2.3 Israel Duloxetine Market Revenues & Volume, By Fibromyalgia Agents, 2021- 2031F |
6.2.4 Israel Duloxetine Market Revenues & Volume, By Selective Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs), 2021- 2031F |
6.3 Israel Duloxetine Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Israel Duloxetine Market Revenues & Volume, By Neuropathic Pain, 2021- 2031F |
6.3.3 Israel Duloxetine Market Revenues & Volume, By Major Depressive Disorder, 2021- 2031F |
6.3.4 Israel Duloxetine Market Revenues & Volume, By Fibromyalgia, 2021- 2031F |
6.3.5 Israel Duloxetine Market Revenues & Volume, By Generalized Anxiety Disorder (GAD), 2021- 2031F |
6.3.6 Israel Duloxetine Market Revenues & Volume, By Chronic Musculoskeletal Pain, 2021- 2031F |
6.3.7 Israel Duloxetine Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Israel Duloxetine Market, By Type |
6.4.1 Overview and Analysis |
6.4.2 Israel Duloxetine Market Revenues & Volume, By Generic, 2021- 2031F |
6.4.3 Israel Duloxetine Market Revenues & Volume, By Brand, 2021- 2031F |
6.5 Israel Duloxetine Market, By Dosage Form |
6.5.1 Overview and Analysis |
6.5.2 Israel Duloxetine Market Revenues & Volume, By Oral Delayed Release Capsule, 2021- 2031F |
6.5.3 Israel Duloxetine Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Israel Duloxetine Market, By Route of Administration |
6.6.1 Overview and Analysis |
6.6.2 Israel Duloxetine Market Revenues & Volume, By Oral, 2021- 2031F |
6.6.3 Israel Duloxetine Market Revenues & Volume, By Others, 2021- 2031F |
6.7 Israel Duloxetine Market, By End-Users |
6.7.1 Overview and Analysis |
6.7.2 Israel Duloxetine Market Revenues & Volume, By Clinic, 2021- 2031F |
6.7.3 Israel Duloxetine Market Revenues & Volume, By Hospital, 2021- 2031F |
6.7.4 Israel Duloxetine Market Revenues & Volume, By , 2021- 2031F |
6.8 Israel Duloxetine Market, By Distribution Channel |
6.8.1 Overview and Analysis |
6.8.2 Israel Duloxetine Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.8.3 Israel Duloxetine Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.8.4 Israel Duloxetine Market Revenues & Volume, By , 2021- 2031F |
7 Israel Duloxetine Market Import-Export Trade Statistics |
7.1 Israel Duloxetine Market Export to Major Countries |
7.2 Israel Duloxetine Market Imports from Major Countries |
8 Israel Duloxetine Market Key Performance Indicators |
8.1 Number of mental health clinics and facilities offering duloxetine treatment |
8.2 Patient adherence rate to duloxetine therapy |
8.3 Number of healthcare professionals trained in prescribing duloxetine |
9 Israel Duloxetine Market - Opportunity Assessment |
9.1 Israel Duloxetine Market Opportunity Assessment, By Strength, 2021 & 2031F |
9.2 Israel Duloxetine Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.3 Israel Duloxetine Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 Israel Duloxetine Market Opportunity Assessment, By Type, 2021 & 2031F |
9.5 Israel Duloxetine Market Opportunity Assessment, By Dosage Form, 2021 & 2031F |
9.6 Israel Duloxetine Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.7 Israel Duloxetine Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.7 Israel Duloxetine Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Israel Duloxetine Market - Competitive Landscape |
10.1 Israel Duloxetine Market Revenue Share, By Companies, 2024 |
10.2 Israel Duloxetine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here